R&D Day for shareholders
November 13 2006 - 2:30AM
UK Regulatory
RNS Number:9119L
Tepnel Life Sciences PLC
13 November 2006
FOR IMMEDIATE RELEASE
Tepnel Life Sciences plc ("Tepnel" or the "Company")
Announcement of R&D Day for shareholders
Manchester, UK. 13th November 2006; Tepnel Life Sciences plc (AIM: TED), the
UK-based international Molecular Diagnostics and Research Products & Services
group, announces that it will be holding an R&D day on Thursday December 7th
2006 to update shareholders on the development of future products and services.
Date: Thursday 7th December 2006
Time: 9.00am - 1.00pm
Venue: The Royal Society of Medicine
Lower Atrium Theatre
1 Wimpole Street, London. W1G 0AE
United Kingdom
Full details can we found in the Investor Relations section at www.tepnel.com.
To register, contact Joanna Dixon at De Facto Communications. Please send her an
email (j.dixon@defacto.com ) or call her on +44 (0)20 7861 3042.
Enquiries:
Ben Matzilevich, Chief Executive Officer, Tepnel Life Sciences plc 0161 946 2200
Mark Percy, Seymour Pierce Limited 0207 107 8000
Richard Anderson, De Facto Communications Ltd 0207 861 3838
About Tepnel Life Sciences plc:
Tepnel is a UK-based international life sciences company focused on molecular
diagnostics and research products and services including DNA purification kits
and reagents, scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods. Tepnel was founded in 1992 to exploit
DNA technology generated at UMIST (University of Manchester Institute of Science
and Technology) and is quoted on the AIM segment of the London Stock Exchange
(AIM: TED). More information on Tepnel can be found at www.tepnel.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCILFVSLDLILIR
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024